Kenichi Yoshimura

10.1k total citations
247 papers, 4.5k citations indexed

About

Kenichi Yoshimura is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Kenichi Yoshimura has authored 247 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Pulmonary and Respiratory Medicine, 103 papers in Oncology and 64 papers in Surgery. Recurrent topics in Kenichi Yoshimura's work include Lung Cancer Treatments and Mutations (39 papers), Gastric Cancer Management and Outcomes (28 papers) and Lung Cancer Diagnosis and Treatment (26 papers). Kenichi Yoshimura is often cited by papers focused on Lung Cancer Treatments and Mutations (39 papers), Gastric Cancer Management and Outcomes (28 papers) and Lung Cancer Diagnosis and Treatment (26 papers). Kenichi Yoshimura collaborates with scholars based in Japan, United States and Switzerland. Kenichi Yoshimura's co-authors include Miyuki Niimi, Satoshi Teramukai, Masashi Kanai, Manabu Muto, Masakazu Toi, Shujiro Yazumi, Tsutomu Chiba, Kazuhiro Yanagihara, Masanori Asada and Takafumi Nishimura and has published in prestigious journals such as The Journal of Chemical Physics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kenichi Yoshimura

232 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenichi Yoshimura Japan 33 1.7k 1.6k 1.2k 680 609 247 4.5k
Yasuo Sakamoto Japan 39 1.8k 1.1× 1.4k 0.8× 2.0k 1.7× 1.3k 1.9× 618 1.0× 179 5.0k
Masahiko Koike Japan 40 2.1k 1.2× 1.9k 1.2× 1.9k 1.6× 1.7k 2.6× 830 1.4× 234 5.4k
Roderich E. Schwarz United States 42 2.2k 1.3× 2.4k 1.5× 2.0k 1.7× 1.2k 1.7× 558 0.9× 184 5.7k
Keisuke Hata Japan 34 2.0k 1.2× 1.2k 0.7× 2.0k 1.6× 839 1.2× 497 0.8× 301 4.7k
Eliane Angst Switzerland 20 1.7k 1.0× 1.1k 0.7× 1.7k 1.4× 1.0k 1.5× 811 1.3× 36 4.9k
Kazushige Kawai Japan 38 3.0k 1.8× 1.1k 0.7× 2.0k 1.7× 913 1.3× 715 1.2× 345 5.4k
Chun‐Nan Yeh Taiwan 41 1.7k 1.0× 2.2k 1.3× 2.7k 2.2× 880 1.3× 601 1.0× 280 5.5k
Ta‐Sen Yeh Taiwan 39 1.9k 1.1× 2.1k 1.3× 2.6k 2.1× 1.2k 1.7× 717 1.2× 242 5.3k
Matthias Anthuber Germany 29 1.5k 0.9× 1.0k 0.6× 1.5k 1.2× 905 1.3× 311 0.5× 156 3.9k
Chie Tanaka Japan 40 1.7k 1.0× 1.9k 1.1× 1.6k 1.3× 1.4k 2.1× 722 1.2× 264 4.6k

Countries citing papers authored by Kenichi Yoshimura

Since Specialization
Citations

This map shows the geographic impact of Kenichi Yoshimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichi Yoshimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichi Yoshimura more than expected).

Fields of papers citing papers by Kenichi Yoshimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenichi Yoshimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichi Yoshimura. The network helps show where Kenichi Yoshimura may publish in the future.

Co-authorship network of co-authors of Kenichi Yoshimura

This figure shows the co-authorship network connecting the top 25 collaborators of Kenichi Yoshimura. A scholar is included among the top collaborators of Kenichi Yoshimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenichi Yoshimura. Kenichi Yoshimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kataoka, Yuki, T. Takayama, Kenichi Yoshimura, et al.. (2025). Automating the data extraction process for systematic reviews using GPT-4o and o3. Research Synthesis Methods. 17(1). 42–62.
2.
3.
Nakamura, Ikuo, Etsuro Hatano, Hideo Baba, et al.. (2023). Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer. Annals of Gastroenterological Surgery. 7(6). 1009–1020. 6 indexed citations
4.
Tanimura, Keiko, Junji Uchino, Hideharu Kimura, et al.. (2023). Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial. The Oncologist. 28(6). 551–e454. 6 indexed citations
5.
Ozaki, Yukinori, Junji Tsurutani, Toru Mukohara, et al.. (2022). Safety and efficacy of nivolumab plus bevacizumab, paclitaxel for HER2-negative metastatic breast cancer: Primary results and biomarker data from a phase 2 trial (WJOG9917B). European Journal of Cancer. 171. 193–202. 24 indexed citations
6.
Ozaki, Yukinori, Junji Tsurutani, Toru Mukohara, et al.. (2022). Data of programmed death-ligand 1 expression and VEGF: Nivolumab, bevacizumab and paclitaxel For HER2-negative metastatic breast cancer. Data in Brief. 45. 108558–108558. 1 indexed citations
7.
Yoshimura, Kenichi, et al.. (2020). Association between the Expertise Level and Experience of Clinical Research Coordinators. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 51(2). 71–76. 1 indexed citations
8.
Yoshida, Naohiro, Hisashi Doyama, Tomonori Yano, et al.. (2020). Early gastric cancer detection in high-risk patients: a multicentre randomised controlled trial on the effect of second-generation narrow band imaging. Gut. 70(1). 67–75. 75 indexed citations
9.
Kagamu, Hiroshi, Shigehisa Kitano, Ou Yamaguchi, et al.. (2019). CD4+ T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy. Cancer Immunology Research. 8(3). 334–344. 169 indexed citations
10.
Takeuchi, Shinji, Tetsunari Hase, Shinobu Shimizu, et al.. (2019). Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double‐positive lung cancer. Cancer Science. 111(2). 561–570. 28 indexed citations
11.
Ogawa‐Ochiai, Keiko, et al.. (2019). The effect of contact needle therapy on fatigue in patients with cancer in palliative care. Medicine. 98(44). e17809–e17809.
12.
13.
14.
Ishida, Takashi, Atae Utsunomiya, Tatsuro Jo, et al.. (2017). Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and II studies. Cancer Science. 108(10). 2022–2029. 52 indexed citations
15.
Iwata, Takekazu, Ichiro Yoshino, Shigetoshi Yoshida, et al.. (2015). Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis (West Japan Oncolgy Group 6711L): A Phase II Study. CHEST Journal. 148(4). 395A–395A. 1 indexed citations
16.
Tanaka, Shiro, et al.. (2012). Statistical Issues and Recommendations for Noninferiority Trials in Oncology: A Systematic Review. Clinical Cancer Research. 18(7). 1837–1847. 31 indexed citations
17.
Okabe, Hiroshi, Akihiko Yoshizawa, Sachiko Minamiguchi, et al.. (2012). HER2 expression and its clinicopathological features in resectable gastric cancer. Gastric Cancer. 16(1). 84–93. 78 indexed citations
18.
Tanioka, Maki, Carlos Shimizu, Kan Yonemori, et al.. (2010). Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy. British Journal of Cancer. 103(3). 297–302. 44 indexed citations
19.
Yoshimura, Kenichi, Masahiro Kuroda, Atsushi Yoshida, et al.. (2004). Development of a phantom compatible for MRI and hyperthermia using carrageenan gel—relationship between dielectric properties and NaCl concentration. International Journal of Hyperthermia. 20(5). 529–538. 15 indexed citations
20.
Doteuchi, Masami, Hidetoshi Sato, Seiichiro Hirono, et al.. (1995). Pharmacological studies of oxycodone hydrochloride. 1. Antinociceptive effect and general pharmacology. 49(3). 257–273. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuo Sakamoto Breakdown of academic impact, for papers by Masahiko Koike Breakdown of academic impact, for papers by Roderich E. Schwarz Breakdown of academic impact, for papers by Keisuke Hata Breakdown of academic impact, for papers by Eliane Angst Breakdown of academic impact, for papers by Kazushige Kawai Breakdown of academic impact, for papers by Chun‐Nan Yeh Breakdown of academic impact, for papers by Ta‐Sen Yeh Breakdown of academic impact, for papers by Matthias Anthuber Breakdown of academic impact, for papers by Chie Tanaka
Rankless by CCL
2026